Quia Pharma AB (publ) (STO:QUIA)
0.0076
-0.0008 (-9.52%)
May 14, 2025, 1:00 PM CET
Quia Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0 | 0.1 | 2.57 | 5.34 | 8.59 | Upgrade
|
Cash & Short-Term Investments | 0 | 0.1 | 2.57 | 5.34 | 8.59 | Upgrade
|
Cash Growth | -98.02% | -96.06% | -51.96% | -37.81% | 88.91% | Upgrade
|
Accounts Receivable | - | - | 0.22 | 0.22 | 0.01 | Upgrade
|
Other Receivables | 0.47 | 0.79 | 0.73 | 0.68 | 0.77 | Upgrade
|
Receivables | 0.47 | 0.79 | 0.95 | 0.9 | 0.77 | Upgrade
|
Prepaid Expenses | 0.58 | 0.27 | 0.25 | 0.05 | 0.1 | Upgrade
|
Other Current Assets | - | 0.6 | - | - | -0 | Upgrade
|
Total Current Assets | 1.05 | 1.76 | 3.76 | 6.29 | 9.46 | Upgrade
|
Property, Plant & Equipment | 0.06 | 0.27 | 0.52 | 0.78 | 0.94 | Upgrade
|
Other Intangible Assets | 21.64 | 32.66 | 12.28 | 10.92 | 10.14 | Upgrade
|
Long-Term Deferred Charges | - | 7.27 | 6.88 | 5.78 | - | Upgrade
|
Total Assets | 22.75 | 41.96 | 23.44 | 23.76 | 20.54 | Upgrade
|
Accounts Payable | 3.77 | 3.18 | 1.33 | 2.84 | 1.05 | Upgrade
|
Accrued Expenses | 1.51 | 1.25 | 3.07 | 1.55 | 2.47 | Upgrade
|
Current Portion of Long-Term Debt | 1.11 | 20.61 | 0.32 | 0.78 | 4.6 | Upgrade
|
Current Income Taxes Payable | - | 0.3 | 0.19 | 0.23 | 0.33 | Upgrade
|
Other Current Liabilities | - | 1.36 | 0.91 | 1.32 | 10.87 | Upgrade
|
Total Current Liabilities | 6.4 | 26.71 | 5.82 | 6.72 | 19.32 | Upgrade
|
Long-Term Debt | - | - | 15.21 | 17.02 | 1.15 | Upgrade
|
Total Liabilities | 6.4 | 26.71 | 21.03 | 23.74 | 20.47 | Upgrade
|
Common Stock | 23.78 | 23.31 | 23.69 | 42.67 | 49.79 | Upgrade
|
Additional Paid-In Capital | 13.33 | 12.63 | 22.52 | 29.43 | 26.54 | Upgrade
|
Retained Earnings | -20.76 | -20.69 | -43.81 | -72.08 | -76.26 | Upgrade
|
Comprehensive Income & Other | - | - | - | - | -0 | Upgrade
|
Shareholders' Equity | 16.35 | 15.25 | 2.41 | 0.02 | 0.07 | Upgrade
|
Total Liabilities & Equity | 22.75 | 41.96 | 23.44 | 23.76 | 20.54 | Upgrade
|
Total Debt | 1.11 | 20.61 | 15.52 | 17.8 | 5.75 | Upgrade
|
Net Cash (Debt) | -1.11 | -20.51 | -12.96 | -12.46 | 2.84 | Upgrade
|
Net Cash Per Share | -0.00 | -0.28 | -7.31 | -19.88 | 6.87 | Upgrade
|
Filing Date Shares Outstanding | 1,683 | 74.5 | 2.37 | 0.85 | 0.61 | Upgrade
|
Total Common Shares Outstanding | 1,683 | 74.5 | 2.37 | 0.85 | 0.55 | Upgrade
|
Working Capital | -5.35 | -24.94 | -2.06 | -0.43 | -9.86 | Upgrade
|
Book Value Per Share | 0.01 | 0.20 | 1.02 | 0.03 | 0.13 | Upgrade
|
Tangible Book Value | -5.29 | -17.41 | -9.86 | -10.89 | -10.07 | Upgrade
|
Tangible Book Value Per Share | -0.00 | -0.23 | -4.16 | -12.76 | -18.21 | Upgrade
|
Machinery | - | 1.27 | 1.27 | 1.27 | 1.19 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.